Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp

NAS:ADPT (USA)  
$ 4.04 -0.19 (-4.49%) 10:08 PM EST
At Loss
P/B:
2.17
Market Cap:
$ 595.37M
Enterprise V:
$ 382.99M
Volume:
859.24K
Avg Vol (2M):
1.46M
Trade In:
Volume:
859.24K
At Loss
Avg Vol (2M):
1.46M

Business Description

Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Name Current Vs Industry Vs History
Cash-To-Debt 3.2
Equity-to-Asset 0.44
Debt-to-Equity 0.35
Debt-to-EBITDA -0.54
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.89
Distress
Grey
Safe
Beneish M-Score -2.62
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.1
9-Day RSI 58.21
14-Day RSI 59.12
6-1 Month Momentum % -25.24
12-1 Month Momentum % -60.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.51
Quick Ratio 4.35
Cash Ratio 3.72
Days Inventory 83.85
Days Sales Outstanding 72.67
Days Payable 38.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8
Shareholder Yield % 1.43

Financials (Next Earnings Date:2024-08-01)

ADPT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Adaptive Biotechnologies Corp Operating Data

ADPT's Complete Operating Data
No operating data available for Adaptive Biotechnologies Corp.

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ADPT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Adaptive Biotechnologies Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 174.502
EPS (TTM) ($) -1.49
Beta 2.05
Volatility % 69.44
14-Day RSI 59.12
14-Day ATR ($) 0.259424
20-Day SMA ($) 3.6975
12-1 Month Momentum % -60.26
52-Week Range ($) 2.28 - 8.51
Shares Outstanding (Mil) 147.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adaptive Biotechnologies Corp Filings

Filing Date Document Date Form
No Filing Data

Adaptive Biotechnologies Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Adaptive Biotechnologies Corp Frequently Asked Questions

What is Adaptive Biotechnologies Corp(ADPT)'s stock price today?
The current price of ADPT is $4.04. The 52 week high of ADPT is $8.51 and 52 week low is $2.28.
When is next earnings date of Adaptive Biotechnologies Corp(ADPT)?
The next earnings date of Adaptive Biotechnologies Corp(ADPT) is 2024-08-01.
Does Adaptive Biotechnologies Corp(ADPT) pay dividends? If so, how much?
Adaptive Biotechnologies Corp(ADPT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1